IME Stock Overview
Offers cloud-based medical imaging solutions in Australia and internationally.
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 2/6 |
Past Performance | 0/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
ImExHS Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | AU$0.48 |
52 Week High | AU$0.70 |
52 Week Low | AU$0.47 |
Beta | 1.24 |
1 Month Change | -12.73% |
3 Month Change | -26.15% |
1 Year Change | -12.73% |
3 Year Change | -72.09% |
5 Year Change | -72.57% |
Change since IPO | -64.44% |
Recent News & Updates
Recent updates
Improved Revenues Required Before ImExHS Limited (ASX:IME) Shares Find Their Feet
Jan 02ImExHS Limited (ASX:IME) Screens Well But There Might Be A Catch
Jun 07Is ImExHS (ASX:IME) Using Too Much Debt?
Mar 09Market Sentiment Around Loss-Making ImExHS Limited (ASX:IME)
Mar 19Did You Miss ImExHS' (ASX:IME) 60% Share Price Gain?
Feb 11Shareholder Returns
IME | AU Healthcare Services | AU Market | |
---|---|---|---|
7D | -4.0% | 1.4% | 0.7% |
1Y | -12.7% | 74.6% | 7.8% |
Return vs Industry: IME underperformed the Australian Healthcare Services industry which returned 74.6% over the past year.
Return vs Market: IME underperformed the Australian Market which returned 7.8% over the past year.
Price Volatility
IME volatility | |
---|---|
IME Average Weekly Movement | 7.5% |
Healthcare Services Industry Average Movement | 7.7% |
Market Average Movement | 9.0% |
10% most volatile stocks in AU Market | 17.6% |
10% least volatile stocks in AU Market | 3.4% |
Stable Share Price: IME's share price has been volatile over the past 3 months.
Volatility Over Time: IME's weekly volatility (7%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2001 | 400 | German Arango | www.imexhs.com |
ImExHS Limited offers cloud-based medical imaging solutions in Australia and internationally. It offers a medical imaging software that is focused on the development and sale of modular imaging systems, which include information systems for radiology, cardiology, and pathology, as well as a picture archiving and communications system. The company’s solutions include AQUILA, a radiology software solution; ALULA, a pathology software solution; Antero, a cardiology software solution; and STELLA AI, a set of artificial intelligence tools that support specialists in the diagnosis.
ImExHS Limited Fundamentals Summary
IME fundamental statistics | |
---|---|
Market cap | AU$21.86m |
Earnings (TTM) | -AU$4.19m |
Revenue (TTM) | AU$19.89m |
1.1x
P/S Ratio-5.2x
P/E RatioIs IME overvalued?
See Fair Value and valuation analysisEarnings & Revenue
IME income statement (TTM) | |
---|---|
Revenue | AU$19.89m |
Cost of Revenue | AU$11.80m |
Gross Profit | AU$8.09m |
Other Expenses | AU$12.28m |
Earnings | -AU$4.19m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.092 |
Gross Margin | 40.68% |
Net Profit Margin | -21.08% |
Debt/Equity Ratio | 7.9% |
How did IME perform over the long term?
See historical performance and comparison